Area of research
Infectious Diseases · Molecular Biology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, Glycosylation and Glycoproteins Research, COVID-19 Clinical Research Studies, and Animal Virus Infections Studies.
A Bioorthogonal Precision Tool for human N-acetylglucosaminyltransferase V
TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry
Structural dynamics in the evolution of SARS-CoV-2 spike glycoprotein
Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth
Cell-specific bioorthogonal tagging of glycoproteins
The effect of spike mutations on SARS-CoV-2 neutralization
The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV-2
SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity
Structure and binding properties of Pangolin-CoV spike glycoprotein inform the evolution of SARS-CoV-2
Optimization of Metabolic Oligosaccharide Engineering with Ac<sub>4</sub>GalNAlk and Ac<sub>4</sub>GlcNAlk by an Engineered Pyrophosphorylase
Metabolic Engineering Optimizes Bioorthogonal Glycan Labeling in Living Cells
Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion
SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects
Metabolic precision labeling enables selective probing of O-linked <i>N</i> -acetylgalactosamine glycosylation
Scalable and robust SARS-CoV-2 testing in an academic center
Author Correction: Scalable and robust SARS-CoV-2 testing in an academic center